Shanghai Haohai Biological Technology Co Ltd

688366

Company Profile

  • Business description

    Shanghai Haohai Biological Technology Co Ltd is engaged in the manufacturing and sale of biologicals, medical hyaluronate, and ophthalmology products. The Company's operating activities are related to a single operating segment, which is the manufacture and sale of biologicals, medical hyaluronate, and intraocular lenses, research and development of biological engineering and pharmaceutical products, and the provision of related services. Its products are categorized into four types, comprising ophthalmology, medical aesthetics, orthopedics, and anti-adhesion. Geographically, it has operations in Mainland China, which is the key revenue driver, the United States, the United Kingdom, and other countries.

  • Contact

    No. 1386 Hongqiao Road
    23rd Floor, WenGuang Plaza
    Changning District
    Shanghai
    CHN

    T: +86 2152293555

    https://www.3healthcare.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2026

    Employees

    2,110

Stocks News & Analysis

stocks

AI driving growth for ASX tech share

ASX tech share raises funds to facilitate customer AI spend.
stocks

OpenAI is going public as the worst value among its peers

Investors are paying a steep price relative to the underlying business quality, PitchBook research says.
stocks

Wide moat healthcare leader remains undervalued

ASX healthcare giant expected to see uptick in demand from emerging markets.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,855.9079.60-0.89%
CAC 408,199.2918.95-0.23%
DAX 4024,616.22142.83-0.58%
Dow JONES (US)50,786.0180.77-0.16%
FTSE 10010,373.205.150.05%
HKSE24,657.06304.89-1.22%
NASDAQ25,929.66220.230.86%
Nikkei 22564,024.602,563.52-3.85%
NZX 50 Index13,030.947.30-0.06%
S&P 5007,405.7321.990.30%
S&P/ASX 2008,625.1080.00-0.92%
SSE Composite Index3,959.3468.40-1.70%

Market Movers